Xavier Becerra is reflecting on tenure as HHS secretary. He told Scripps News, "We're leaving this country healthier and stronger."

The agency will announce the 15 new drugs chosen for Medicare negotiation on Friday morning. The companies that manufacture these drugs will have until Feb. 28 to sign negotiation agreement. Health and Human Services Secretary Xavier Becerra called the ...

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in Medicare.

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with disabilities, federal health officials announced in a news release.

As of Monday, FDA commissioner Robert Califf, Department of Health and Human Services (HHS) Secretary Xavier Becerra, Medicare director Meena Seshamani, and FDA Center for Drug Evaluation and Research director Patrizia Cavazzoni have retired or intend to retire prior to Trump's inauguration on Jan. 20.

WASHINGTON — Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications ... big deal,” U.S. Health and Human Services Secretary Xavier Becerra said in a call with reporters on Thursday.

The fact that Medicare spends so much on 25 drugs — out of the roughly 8,000 medications it covers — shows the importance of being able to negotiate better prices, Health and Human Services Secretary Xavier Becerra told reporters. “It lets us go ...

Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in lower prices for patients, the Department of Health and Human Services confirmed Friday.

On Friday, the Centers for Medicare & Medicaid Services (CMS ... important drugs for seniors," Department of Health and Human Services Secretary Xavier Becerra said. Becerra said the agency "will continue negotiating in the best interest of people with ...

U.S. Health and Human Services Secretary Xavier Becerra says “this is a big deal.” Drug companies oppose the program.

President Donald Trump’s decision to tap Robert F. Kennedy Jr. to lead the nation’s top health agency has elicited criticism from abortion-rights supporters and opponents. Kennedy’s confirmation hearing before the U.

He also would oversee the Centers for Medicare and Medicaid Services, which, as the name implies, manages those two programs. HHS services, in other words, touch the lives of every American—and Medicaid and Medicare are,